Geoffrey E. Harris Insider Trading $CGIX Vyant Bio, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Geoffrey E. Harris.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geoffrey E. Harris. Geoffrey E. Harris is Director in MYnd Analytics, Inc. ($CNSO) and Director in American CareSource Holdings, Inc. ($GNOW) and Director in CANCER GENETICS, INC ($CGIX).
Geoffrey E. Harris in Vyant Bio, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Geoffrey E. Harris: Director
Holdings: 127,500 shares
Current Value: $306,000
Latest Transaction: Apr 01 2021
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Geoffrey E. Harris in Vyant Bio, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNOW, MYND, CGIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | CGIX | Vyant Bio, Inc. | Harris Geoffrey E. | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
| Apr 01 2021 | CGIX | Vyant Bio, Inc. | Harris Geoffrey E. | Director | Option Exercise | A | 4.61 | 13,015 | 59,999 | 13,015 | |
| Aug 19 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
| Jan 16 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 0.23 | 100,000 | 22,500 | 127,500 | 27.5 K to 127.5 K (+363.64 %) |
| Jan 16 2019 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 0.23 | 100,000 | 22,500 | 127,500 | 27.5 K to 127.5 K (+363.64 %) |
| Oct 02 2017 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 2.75 | 5,000 | 13,750 | 5,000 | |
| Oct 02 2017 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Grant | A | 0.00 | 2,500 | 0 | 27,500 | 25 K to 27.5 K (+10.00 %) |
| Jun 08 2017 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
| Jun 08 2017 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Grant | A | 0.00 | 2,500 | 0 | 25,000 | 22.5 K to 25 K (+11.11 %) |
| May 16 2017 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 3.75 | 2,500 | 9,375 | 22,500 | 20 K to 22.5 K (+12.50 %) |
| Dec 14 2016 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 1.50 | 2,500 | 3,750 | 20,000 | 17.5 K to 20 K (+14.29 %) |
| Nov 16 2016 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 1.55 | 5,000 | 7,750 | 17,500 | 12.5 K to 17.5 K (+40.00 %) |
| Oct 13 2016 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 1.81 | 10,000 | 18,100 | 10,000 | |
| Oct 13 2016 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
| May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 10.79 | 5,000 | 53,949 | 5,000 | 0 to 5 K |
Page: 1